Denise Scots-Knight

CIK 1297000 · Chief Executive Officer · last filed 2026-05-26

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.82M

Companies

5

Total Filings

38

Lifetime Open-Market Net

-$844.9K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ELAN Director 105,588 $24.17 $2.55M $0 6 2026-05-26
MREO Chief Executive Officer 868,967 $0.30 $265.0K -$844.9K 7 2026-02-02
Elanco Animal Health Inc (ELAT) Delisted Director 39,857 $21.32 $849.8K $0 3 2022-12-02
ALBIREO PHARMA, INC. (ALBO) Delisted Director 1,165,447 $44.15 $51.45M $0 3 2017-06-20
IDENIX PHARMACEUTICALS INC (IDIX) Delisted Director $0 8 2014-08-05

Recent Filings · Page 3 of 4

38 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-11-07 ALBIREO PHARMA, INC. (ALBO) Delisted Grant (A) +1,165,447 $0 EDGAR
2016-06-24 Grant (A) $0
2015-06-23 Grant (A) $0
2015-01-02 Sell (S) −3,799 -$82.3K
2014-12-30 Sell (S) −17,607 -$380.9K
2014-12-23 Sell (S) −20,654 -$448.3K
2014-12-10 Sell (S) −32,940 -$717.3K
2014-12-05 Sell (S) −25,000 -$540.0K
2014-08-05 IDENIX PHARMACEUTICALS INC (IDIX) Delisted Disp (D) $0 EDGAR
2014-07-02 Sell (S) −11,485 -$270.9K
Showing 2130 of 38
Page 3 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.